

Neuronetics (NASDAQ:STIM) reported third-quarter financial results on Wednesday. The transcript from the company’s third-quarter earnings call has been provided...
You can purchase shares of Neuronetics (NASDAQ:STIM) through any online brokerage.
Other companies in Neuronetics’s space includes: Abbott Laboratories (NYSE:ABT), Intuitive Surgical Inc (NASDAQ:ISRG), Medtronic PLC (NYSE:MDT), Stryker Corp (NYSE:SYK) and Boston Scientific Corp (NYSE:BSX).
Neuronetics has a consensus price target of $5.33.
The stock price for Neuronetics (NASDAQ: STIM) is $2.695 last updated November 4, 2026 at 2:40 PM EST.
There are no upcoming dividends for Neuronetics.
Neuronetics does not have any upcoming earnings scheduled.
There is no upcoming split for Neuronetics.
Neuronetics is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.
Neuronetics Inc a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar...